enabling clinical development of poorly soluble molecules through formulation solutions
Published 3 years ago • 340 plays • Length 55:12Download video MP4
Download video MP3
Similar videos
-
6:29
amorphous solid dispersion — ideal approach to improve developability of poorly soluble molecules
-
45:48
amorphous solid dispersion — an ideal formulation approach to improve developability
-
44:50
webinar accelerating biologics development to medicines - key drivers of success
-
6:00
hpv pseudovirus neutralization assay
-
3:19
analytical research facility at aragen
-
3:01
abbvie & enanta pharmaceuticals - 2023 heroes of chemistry
-
3:14
covid-19 preventive measures at aragen
-
1:28
supplier insider: aragen
-
2:11
allied health solutions laboratory diagnostics
-
2:19
genetic lab solution | evicore healthcare
-
7:00
disease infosearch is in need of funding
-
3:19
laboratory alliance: impact of the genexpert® system and xpert® flu/rsv xc on patient care
-
2:27
oligo resuspension and storage tips | dharmacon™ oligo synthesis tips | episode 6
-
14:59
new approaches to prevent adverse complement activation: implications for nanomedicine
-
1:00:52
shira abeles, md - pandemic: factors driving spillover and emergence of infectious diseases (update)
-
19:46
optimally locating opioid treatment centers in under served areas using r and alteryx
-
0:48
future directions for apobec studies
-
0:40
disease infosearch is finally here!
-
24:23
intelllgent pharma: hpc tools to discover new drugs
-
2:13
learn how the rna-out antibiotic-free selection system works in the nanoplasmid® vector